How Logiqcare supported the PROSPERA trial

The PROSPERA program is a population-level, risk-based cardiovascular prevention initiative designed to improve cardiovascular risk management (CVRM) in primary care. With cardiovascular disease (CVD) continuing to place increasing pressure on healthcare systems, particularly general practice, there is a growing need for more personalized and efficient prevention strategies. PROSPERA aims to address this challenge by tailoring preventive interventions to each patient’s individual cardiovascular risk profile.

The study is being conducted as a pragmatic 1:1 cluster-randomized controlled trial across 22 primary care practices in the Leiden and The Hague regions of the Netherlands. By identifying patients at elevated cardiovascular risk and targeting preventive efforts where they are most effective, the program seeks to improve both efficiency and quality of care.

In addition to clinical outcomes, the study evaluates several implementation and patient-centred outcomes, including:

  • Penetration and fidelity of the intervention
  • Healthcare professionals’ satisfaction with the usability of the PROSPERA tools
  • Patient experiences with shared decision-making
  • Decisional conflict during healthcare decision-making
  • Cost-effectiveness of the program

Supporting Clinical Decision-Making with U-Prevent

A key component of the PROSPERA program is U-Prevent, which was used to:

  • Assess each patient’s individual cardiovascular risk profile
  • Explore the potential benefits of lifestyle and medication-based interventions
  • Support shared decision-making between patients and healthcare professionals

During every U-Prevent consultation, relevant patient characteristics, risk calculations, treatment scenarios, and projected risk reductions were recorded. Together with contextual information such as practice location, date and time, and the calculator version used, this information was automatically stored in LogiqSuite, Logiqcare’s Medical Data Management platform.

Real-Time Research Monitoring Through LogiqAnalytics

All structured data captured in LogiqSuite was made available in real time within LogiqAnalytics, a subsystem of LogiqSuite designed for research monitoring and data analysis.

This provided researchers with continuous insight into study progress, including patient inclusion rates across participating practices. Potential delays or deviations from recruitment targets could therefore be identified early and addressed promptly, helping participating practices remain on track.

Perhaps even more importantly, the use of structured and centrally managed data eliminated the traditional delay between study completion and data preparation. Researchers could begin data analysis immediately after study closure, significantly accelerating the evaluation process.

Seamless Integration with Primary Care Workflows

Healthcare professionals also benefited from the U-Prevent Connect API, which enabled automatic retrieval of patient information from LogiqSuite and pre-filled the U-Prevent calculator.

This integration offered two important advantages:

  • Reduced administrative burden and consultation time
  • Minimized the risk of manual data-entry errors

By embedding risk prediction devices directly into existing clinical workflows, the solution improved both efficiency and data quality.

Demonstrating the Value of Connected Care and Research Data

While the final scientific outcomes of the PROSPERA trial are eagerly anticipated, the program has already demonstrated the benefits of connecting risk prediction devices with electronic health record systems and capturing consultation data in a structured research-ready format.

By combining U-Prevent and LogiqSuite, healthcare organizations and researchers gain immediate access to high-quality data for research, benchmarking, outcome monitoring, and population health analysis, both during and after a study.

Interested in learning how U-Prevent and LogiqSuite can support your clinical research programs, population health initiatives, or cardiovascular prevention strategies? Contact Logiqcare to learn more.

To learn more about the PROSPERA program read the publication: https://bmjopen.bmj.com/content/16/10/e118002.full

 

Write your comment Here